• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4
4
4
2

COUNTRY

3
1

CATEGORIES

  • 5
  • 2
  • 1
  • 1

PRICE

2
2
2
8

PUBLISHED

0
1
1
8

PRODUCT TYPE

6
2

Search "OccuLogix Inc.-Financial Company Report" returned 8 results.

TearLab Corporation (formerly OccuLogix, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

May 2015
FROM

North America Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015

North America Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to North America ophthalmic...

November 2009
FROM

United States Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015

United States Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to the USA ophthalmic...

November 2009
FROM

North America Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

North America Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for in-depth information and data relating to North America ophthalmic...

January 2009
FROM

Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015

Canada Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 Summary This report is an essential source for in-depth information and data relating to Canada ophthalmic devices...

November 2009
FROM

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ million by the following Therapeutic Categories: - Glaucoma - Anti-allergy - Anti-infective - Dry Eye - Anti-inflammation...

October 2010
FROM

Global Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Global Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012 Summary This report is an essential source for key information and data relating to the Global ophthalmic devices...

December 2008
FROM

OccuLogix, Inc. Deals and Alliances Profile

- This profile is an essential source for company data and information. The profile examines OccuLogix, Inc.’s key business structure and operations, history and products, and provides summary analysis...

July 2007
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group